Capital Southwest Announces Financial Results for Second Fiscal Quarter Ended September 30, 2016
Nov 07, 2016 21:02 pm UTC| Business
DALLAS, Nov. 07, 2016 -- Capital Southwest Corporation (“Capital Southwest” or the “Company”) (Nasdaq:CSWC) today announced its financial results for the second fiscal quarter ended September30, 2016. Second Quarter...
Pernix Therapeutics Appoints Two Board Members
Nov 07, 2016 21:01 pm UTC| Business
MORRISTOWN, N.J., Nov. 07, 2016 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced the appointment of Graham G. Miao, Ph.D....
Zogenix Provides Corporate Update and Reports Third Quarter 2016 Financial Results
Nov 07, 2016 21:01 pm UTC| Business
EMERYVILLE, Calif., Nov. 07, 2016 -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today provided a corporate update...
Celldex Reports Third Quarter 2016 Results
Nov 07, 2016 21:01 pm UTC| Business
HAMPTON, N.J., Nov. 07, 2016 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2016. “Celldex continues to demonstrate our...
Rockwell Medical Reports Third Quarter Results
Nov 07, 2016 21:01 pm UTC| Business
WIXOM, Mich., Nov. 07, 2016 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and...
MaxLinear, Inc. Announces Third Quarter 2016 Financial Results
Nov 07, 2016 21:01 pm UTC| Business
CARLSBAD, Calif., Nov. 07, 2016 -- MaxLinear, Inc. (NYSE:MXL), a leading provider of radio frequency (RF) and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and...
Fate Therapeutics Reports Third Quarter 2016 Financial Results
Nov 07, 2016 21:01 pm UTC| Business
IND Filed for FATE-NK100 Adaptive Natural Killer Cell Immunotherapy in Acute Myeloid Leukemia Orphan Drug Designations for ProTmune Granted by FDA and EMA ProTmune™ PROTECT Clinical Protocol Amended to Facilitate Path...
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.